Bristol-Myers Squibb

Bio & Pharma Lotte Biologics to break ground on 1st local CDMO plant in 2024

South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...

Bio & Pharma Samsung Biologics wins $242 mn order from Bristol Myers Squibb

Samsung Biologics Co., the world’s largest contract drugmaker, said on Monday it has signed an agreement to produce $242 million worth of anti...

Mergers & Acquisitions Lotte to buy BMS' biologics plant in Syracuse for $160 mn

South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...